← Back to Search

Psychotherapy for PTSD Due to Military Sexual Trauma

N/A
Recruiting
Led By JoAnn Difede, PhD
Research Sponsored by Weill Medical College of Cornell University
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Ability to provide informed consent and function at an intellectual level sufficient to allow accurate completion of all assessment instruments
Be older than 18 years old
Must not have
Lifetime or current diagnosis of schizophrenia or other psychotic disorder, bipolar disorder
Timeline
Screening 3 weeks
Treatment Varies
Follow Up baseline, 15 weeks in the ipt condition, 11 weeks in the et condition
Awards & highlights

Summary

This trial is comparing two types of therapy to see which is more effective in treating PTSD due to Military Sexual Trauma.

Who is the study for?
This trial is for male and female military personnel who have PTSD due to Military Sexual Trauma (MST). Participants must speak English, be able to consent, have been stable on psychotropic medication for 60 days, and score over 40 on the CAPS assessment. They should not have unstable medical conditions or substance dependence in the last 90 days.
What is being tested?
The study compares Exposure Therapy (ET) with Interpersonal Psychotherapy (IPT) to treat PTSD from MST. It aims to determine if both therapies are equally effective, potentially broadening treatment options for those affected by MST.
What are the potential side effects?
While specific side effects are not listed for these therapies, common reactions can include temporary increases in distress, emotional discomfort during sessions, and potential strain in personal relationships outside of therapy.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I can understand and agree to the study's requirements.

Exclusion Criteria

You may be eligible for the trial if you check “No” for criteria below:
Select...
I have been diagnosed with schizophrenia, bipolar disorder, or another psychotic disorder.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~baseline, 15 weeks in the ipt condition, 11 weeks in the et condition
This trial's timeline: 3 weeks for screening, Varies for treatment, and baseline, 15 weeks in the ipt condition, 11 weeks in the et condition for reporting.

Treatment Details

Study Objectives

Study objectives can provide a clearer picture of what you can expect from a treatment.
Primary study objectives
Change in CAPS-5 scores from baseline to post-treatment for the ET treatment group
Change in CAPS-5 scores from baseline to post-treatment for the IPT treatment group
Difference in mean Clinician Administered PTSD Scale-5 (CAPS-5) score changes between the Exposure Therapy (ET) and Interpersonal Psychotherapy (IPT) treatment groups from baseline to post-treatment

Trial Design

2Treatment groups
Active Control
Group I: Interpersonal PsychotherapyActive Control1 Intervention
Participants receive 14 weekly 50-minute Interpersonal Psychotherapy sessions focused on the interpersonal sequelae of trauma in current daily life.
Group II: Exposure TherapyActive Control1 Intervention
Participants receive 10 90-minute exposure therapy sessions for PTSD following the treatment procedures as outlined in the standard Prolonged Exposure therapy manual.

Find a Location

Who is running the clinical trial?

Weill Medical College of Cornell UniversityLead Sponsor
1,077 Previous Clinical Trials
1,320,459 Total Patients Enrolled
United States Department of DefenseFED
891 Previous Clinical Trials
332,270 Total Patients Enrolled
JoAnn Difede, PhDPrincipal InvestigatorWeill Medical College of Cornell University
5 Previous Clinical Trials
256 Total Patients Enrolled

Media Library

Exposure Therapy Clinical Trial Eligibility Overview. Trial Name: NCT03803332 — N/A
Post-Traumatic Stress Disorder Research Study Groups: Interpersonal Psychotherapy, Exposure Therapy
Post-Traumatic Stress Disorder Clinical Trial 2023: Exposure Therapy Highlights & Side Effects. Trial Name: NCT03803332 — N/A
Exposure Therapy 2023 Treatment Timeline for Medical Study. Trial Name: NCT03803332 — N/A
Post-Traumatic Stress Disorder Patient Testimony for trial: Trial Name: NCT03803332 — N/A
~18 spots leftby Mar 2025
Unbiased ResultsWe believe in providing patients with all the options.
Your Data Stays Your DataWe only share your information with the clinical trials you're trying to access.
Verified Trials OnlyAll of our trials are run by licensed doctors, researchers, and healthcare companies.
Back to top